New Alzheimer's Studies Reveal Disease Biology, Risk for Progression, and the Potential for a Novel Blood Test
Two new papers by an international team of researchers demonstrate that evaluating microRNAs in blood can be used not only to diagnose mild cognitive impairment (MCI) but also to predict the conversion from MCI to dementia due to Alzheimer's disease.
18-Sep-2024 12:05 PM EDT
Add to Favorites